期刊文献+

HPLC-FLD同时测定全血中加替沙星和莫西沙星含量 被引量:6

Determination of Gatifloxacin and Moxifloxacin in Whole Blood by HPLC Coupled with Fluorescence Detection
原文传递
导出
摘要 目的建立一种灵敏、可靠的全血中加替沙星和莫西沙星的高效液相色谱荧光检测方法。方法样品经磷酸盐缓冲液提取后,用Waters OasisMAX小柱进行净化,甲醇-乙腈-0.2%甲酸(15∶15∶70)为流动相,采用Cloversil-C18柱(3.0mm×150mm,5μm)分离,荧光检测波长:λex288nm和λem493nm,内标法定量。结果加替沙星和莫西沙星在15.0~240.0μg·L-1内呈良好线性,方法回收率在97.7%~101.3%之间,日内RSD<6.0%,其定量限为15.0μg·L-1。结论本方法简便、灵敏、干扰少,特异性好,能满足血液中加替沙星和莫西沙星的检测要求。 OBJECTIVE To develop a sensitive and accurate method for the determination of gatifloxacin and moxifloxacin in whole blood by high-performance liquid chromatography coupled with fluorescence detection(HPLC-FLD). METHODS After gatifloxacin and moxifloxacin in whole blood were extracted by phosphate buffer, the sample was cleaned with solid-phase extraction (SPE) using Oasis MAX cartridges.The separation was performed on Cloversil - C18 column (3.0 mm × 150 mm, 5 μm) using the mobile phase consisting of methanol-acetonitrile-0.2% formic acid(15 : 15 : 70).Detection was carried out on a fluorescence detection at λex 288 nm and λem 493 nm. RESULTS Calibration curves were linear within the range of 15.0-240.0 μg·L^-1, and the extraction recoveries were from 97.7% to 101.3%, the RSDs were less than 6.0%.The limits of quantification were found to be 15.0 μg ·L^-1.CONCLUSION This method is found to be simple,sensitive,little interferential and good specificity for the determination of gatifloxacin and moxifloxacin in whole blood.
作者 陈晓红
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第5期412-414,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 高效液相色谱-荧光法 全血 加替沙星 莫西沙星 HPLC-FLD whole blood gatifloxacin moxifloxacin
  • 相关文献

参考文献13

二级参考文献34

  • 1关福玉,刘力,罗毅.高效液相色谱法测定血浆中7种灭鼠剂[J].分析化学,1995,23(2):159-162. 被引量:24
  • 2金米聪,李小平,姚浔平,陈晓红.高效液相色谱法同时测定全血中杀鼠迷和杀鼠灵研究[J].中国卫生检验杂志,2005,15(9):1050-1051. 被引量:22
  • 3杨士云,潘冠民,张大明.血液中溴敌隆的液相色谱-质谱联用分析[J].色谱,2005,23(6):682-682. 被引量:6
  • 4[1]Liang H, Kays MB, Sowinski KMT. Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma [J] . Chromatogr B Analyt Technol Biomed Life Sci, 2002,772 (1): 53.
  • 5[2]Xuan DW,Zhong MK, Mattoes H, et al. Streptococcus pnunoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model [J]. Anticrob Agents Chemother, 2001,45 (3): 794.
  • 6[3]Stass H, Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and introvenous adminstration in man[J]. J Antimicrob Chemother,1994,3 (Suppl B):83.
  • 7[4]Sunderland J, Tobin CM, Hedges AJ, et al.Antimicrobial activity of fluoroquinolone photodegration products determined byparallel-line bioassay and high performance liquid chromatography[ J]. J Antimicrob Chemother ,2001,47 (3) :271.
  • 8[5]Garcia-Saenz MC, Arias-Puente A, Fresnadillo-Martinez MJ, et al. Human aqueous humor levels of oral ciprofloxacin, levofloxacin and moxifloxacin[J]. J Cataract Refract Surg ,2001,27(12): 1969.
  • 9[6]Moller JG, Stass H, Heinnig R, et al. Capillary electrophoresis with laser-induced fluorescence: a routine method to determine moxifloxacin in human body fluids in very small sample volumes [J]. J Chromatogr B, 1998,716:325.
  • 10[7]Ocana JA, Barragan FJ, Callejon M. Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum[J]. Analyst, 2000,125(12) :2322.

共引文献88

同被引文献52

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部